Archive August 2011

Q1Medicare.com Launches Enhanced Medicare Prescription Drug Plan Formulary Browser

Aug31

Saint Augustine, Florida (PRWEB) August 31, 2011Q1Medicare.com launched their enhanced Medicare prescription drug plan Formulary Browser providing users with easy access to all Medicare prescription drug plan formularies used by Medicare Advantage that offer prescription drug coverage (or MAPDs), stand-alone Medicare Part D plans (or PDPs), and even Medicare Special Needs Plans (or SNPs). The […]

PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee

Aug31

WASHINGTON, Aug. 31 The Pharmaceutical Care Management Association issued the following news release:As the Joint Select Committee on Deficit Reduction examines options to reduce the deficit by $1.5 trillion over the next ten years, the Pharmaceutical Care Management Association (PCMA) outlined in a letter to the committee opportunities to leverage greater use of pharmacy benefit […]

BUYINS.NET: SXCI SqueezeTrigger Price is $54.03. There is $48,807,052 That Short Sellers Still Need To Cover.

Aug31

BUYINS.NET / www.squeezetrigger.com is monitoring SXC HEALTH SOLUTIONS CORP (NASDAQ:SXCI) in real time and just received an alert that SXCI is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 896200 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $54.03. […]

Magellan’s Medical Pharmacy Solutions Receives URAC Health Utilization Management Accreditation

Aug31

ICORE Healthcare’s program recognized for clinically sound processes that support optimal outcomes and cost effective care AVON, Conn.(BUSINESS WIRE) Magellan Health Services Inc. (NASDAQ: MGLN) has announced that its Medical Pharmacy Solutions program has been awarded the Health Utilization Management Accreditation from URAC, a Washington, D.C.-based health care accrediting organization that establishes quality standards for […]

Echo Therapeutics to Present at the Stifel Nicolaus Healthcare Conference 2011

Aug31

PHILADELPHIA, Aug. 31, 2011 /PRNewswire/ Echo Therapeutics, Inc. (NASDAQ: ECTE), a company developing its needle-free Symphony? tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude? SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., CEO, President and Chairman of the Board of Echo Therapeutics will present […]

Researchers’ Work from Florida A&M University Focuses on Nanotechnology

Aug31

New investigation results, "Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery," are detailed in a study published in Molecular Membrane Biology. According to the authors of recent research published in the journal Molecular Membrane Biology, "Topical or transdermal drug delivery is challenging because the skin acts as a natural and protective […]

Google to pay $500m over online drug ads [Independent Television News Limited (UK)]

Aug31

Google has agreed to pay $500 million to settle a criminal probe into adverts it accepted for online Canadian pharmacies selling drugs in the United States.The advertisements, featured through Google’s AdWords program, led to illegal imports of prescription drugs into the country, the US Justice Department said.The settlement, which is one of the largest ever […]

Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

SAN DIEGO, Aug. 31, 2011 (GLOBE NEWSWIRE) Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that its wholly-owned subsidiary, NexMed USA, Inc., has received clearance from the U.S. Food and Drug Administration ("FDA") for its third, over-the-counter ("OTC") drug, Diphenhydramine-D?, containing the Company’s NexACT technology."This latest clearance from the FDA of […]

FDA Commissioner Margaret A. Hamburg’s Statement on the Passing of Dr. Charles Edwards

Aug31

WASHINGTON, Aug. 31 The U.S. Department of Health and Human Services’ Food and Drug Administration issued the following statement by Commissioner Margaret A. Hamburg:The death of Dr. Charles Edwards is a great loss to the U.S. Food and Drug Administration and to Americans who enjoy the safest supplies of food and medicine in the world, […]

DGAP-News: Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

Aug31

Apricus Biosciences, Inc.31.08.2011 15:47-SAN DIEGO, 2011-08-31 15:47 CEST (GLOBE NEWSWIRE) Apricus Biosciences, Inc. (‘Apricus Bio’ or the ‘Company’) (Nasdaq:APRI)(http://www.apricusbio.com) announced today that its wholly-owned subsidiary,NexMed USA, Inc., has received clearance from the U.S. Food and DrugAdministration (‘FDA’) for its third, over-the-counter (‘OTC’) drug,Diphenhydramine-D(tm), containing the Company’s NexACT(r) technology.’This latest clearance from the FDA of our […]